Global Cell Therapy Manufacturing Market (2021 to 2030) - by Type of Cell Manufactured, Source of Cell, Scale of Operation, Purpose of Manufacturing and Key Geographical Regions - ResearchAndMarkets.com
Retrieved on:
Wednesday, August 11, 2021
Health, Biotechnology, Zenith Contract Services, National Alliance for Advanced Transportation Battery Cell Manufacture, Bristol Myers Squibb, Partnership, Lisocabtagene maraleucel, Organization, USFDA, B-cell lymphoma, Regenerative medicine, Research, Cell, CMOS, Automation, Growth, Type, Fine chemical
The "Cell Therapy Manufacturing Market by Type of Cell Manufactured, Source of Cell, Scale of Operation, Purpose of Manufacturing and Key Geographical Regions - Industry Trends and Global Forecasts, 2021-2030" report has been added to ResearchAndMarkets.com's offering.
Key Points:
- The "Cell Therapy Manufacturing Market by Type of Cell Manufactured, Source of Cell, Scale of Operation, Purpose of Manufacturing and Key Geographical Regions - Industry Trends and Global Forecasts, 2021-2030" report has been added to ResearchAndMarkets.com's offering.
- In order to address the concerns related to manufacturing, several cell therapy developers (including the larger companies) have turned to contract manufacturing organizations (CMOs).
- The cell therapy manufacturing service landscape features a mix of industry players (including well-established companies, mid-sized firms and start-ups / small companies), as well as several academic institutes.
- As stakeholders strive to mitigate existing challenges and focus on innovation to improve the cell production process, we believe that the market will witness significant growth in mid-long term.